Your browser doesn't support javascript.
loading
The benefits and risks of pembrolizumab in combination with chemotherapy as first-line therapy in small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized control trials.
Liu, Qiangyun; Zhang, Yixuan; Liu, Miaowen; Xu, Ruoxin; Yi, Fengming; Wei, Yiping; Zhu, Shuqiang; Zhang, Wenxiong.
Afiliación
  • Liu Q; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, China.
  • Zhang Y; Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
  • Liu M; Department of Thoracic Surgery, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, China.
  • Xu R; Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
  • Yi F; Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
  • Wei Y; Department of Oncology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, China.
  • Zhu S; Jiangxi Medical College, Nanchang University, Nanchang, 330006, China.
  • Zhang W; Department of Oncology, The Second Affiliated Hospital of Nanchang University, 1 Minde Road, Nanchang, 330006, China.
World J Surg Oncol ; 19(1): 298, 2021 Oct 14.
Article en En | MEDLINE | ID: mdl-34645484

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: World J Surg Oncol Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: World J Surg Oncol Año: 2021 Tipo del documento: Article